SG11202003784TA - Biomarkers of preterm birth - Google Patents

Biomarkers of preterm birth

Info

Publication number
SG11202003784TA
SG11202003784TA SG11202003784TA SG11202003784TA SG11202003784TA SG 11202003784T A SG11202003784T A SG 11202003784TA SG 11202003784T A SG11202003784T A SG 11202003784TA SG 11202003784T A SG11202003784T A SG 11202003784TA SG 11202003784T A SG11202003784T A SG 11202003784TA
Authority
SG
Singapore
Prior art keywords
biomarkers
preterm birth
preterm
birth
Prior art date
Application number
SG11202003784TA
Other languages
English (en)
Inventor
Nir Arbel
San Min Leow
Xiang Qian Lin
Eitan Rubin
Original Assignee
Carmentix Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmentix Pte Ltd filed Critical Carmentix Pte Ltd
Publication of SG11202003784TA publication Critical patent/SG11202003784TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
SG11202003784TA 2017-10-30 2018-10-30 Biomarkers of preterm birth SG11202003784TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201708890Y 2017-10-30
PCT/EP2018/079639 WO2019086410A1 (en) 2017-10-30 2018-10-30 Biomarkers of preterm birth

Publications (1)

Publication Number Publication Date
SG11202003784TA true SG11202003784TA (en) 2020-05-28

Family

ID=64049256

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003784TA SG11202003784TA (en) 2017-10-30 2018-10-30 Biomarkers of preterm birth

Country Status (13)

Country Link
US (1) US20200319197A1 (pt)
EP (1) EP3704270A1 (pt)
JP (1) JP2021501343A (pt)
KR (1) KR20200094742A (pt)
CN (1) CN111542619A (pt)
AU (1) AU2018357888A1 (pt)
BR (1) BR112020008605A2 (pt)
CA (1) CA3080456A1 (pt)
IL (1) IL274325A (pt)
MX (1) MX2020004421A (pt)
SG (1) SG11202003784TA (pt)
TW (1) TW201923347A (pt)
WO (1) WO2019086410A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3150506A1 (en) * 2019-09-22 2021-03-25 Erick GARCIA CORDERO DEVICE AND METHOD FOR ASSESSING RISK OF PREMATURE BIRTH
CN111951969A (zh) * 2020-08-05 2020-11-17 中翰盛泰生物技术股份有限公司 Hbp在高危妊娠预测中的应用
CN112708653B (zh) * 2020-11-26 2023-06-16 中国科学技术大学 一种用月经血预测反复流产和/或诊断反复流产的原因的检测方法
WO2023152203A1 (en) * 2022-02-10 2023-08-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for prediction and monitoring of spontaneous preterm birth
WO2024015934A2 (en) * 2022-07-13 2024-01-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods of diagnostic screening and early detection of adenomyosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US20050255114A1 (en) * 2003-04-07 2005-11-17 Nuvelo, Inc. Methods and diagnosis for the treatment of preeclampsia
US20080090759A1 (en) * 2004-08-30 2008-04-17 Robert Kokenyesi Methods and kits for predicting risk for preterm labor
KR20150003157A (ko) * 2005-12-19 2015-01-08 트러스티즈 오브 터프츠 칼리지 소프트 단백질분해효소 억제자 및 이의 프로-소프트 폼
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102056611A (zh) * 2008-04-14 2011-05-11 Posi维森纳里解决方案有限责任公司 用于获得不同的治疗适应症所需要的血浆孕酮水平的方法和药物组合物
WO2009134452A2 (en) * 2008-05-01 2009-11-05 Swedish Health Services Preterm delivery diagnostic assay
WO2010006070A1 (en) * 2008-07-08 2010-01-14 The Trustees Of The University Of Pennsylvania Method for assessment of folate phenotypes, disease risk, and response to therapy
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
EP2972308B9 (en) * 2013-03-15 2021-01-20 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
WO2017096405A1 (en) * 2015-12-04 2017-06-08 Nx Prenatal Inc. Use of circulating microparticles to stratify risk of spontaneous preterm birth
KR20190046825A (ko) * 2016-08-05 2019-05-07 세라 프로그노스틱스 인코포레이티드 조기 양막 파열 대 특발성 자연 진통으로 인한 조산 예측용 바이오마커

Also Published As

Publication number Publication date
JP2021501343A (ja) 2021-01-14
KR20200094742A (ko) 2020-08-07
WO2019086410A1 (en) 2019-05-09
CA3080456A1 (en) 2019-05-09
CN111542619A (zh) 2020-08-14
TW201923347A (zh) 2019-06-16
MX2020004421A (es) 2020-09-25
BR112020008605A2 (pt) 2020-10-06
AU2018357888A1 (en) 2020-05-28
US20200319197A1 (en) 2020-10-08
EP3704270A1 (en) 2020-09-09
IL274325A (en) 2020-06-30

Similar Documents

Publication Publication Date Title
HK1254669A1 (zh) 用於預測早產的生物標誌物對
IL254980B (en) Prognostic and diagnostic glycan-based markers for brain damage
HK1258615A1 (zh) 創傷性腦損傷的生物標誌物
SG10202111841TA (en) Nanopore-based analysis of protein characteristics
GB201511152D0 (en) Method of diagnosing bladder cancer
IL274325A (en) Biomarkers for preterm birth
GB2566681B (en) Biomarker
HK1231555A1 (zh) 生物標誌物及其用途
HK1251877A1 (zh) 生物標記和預測方法
SG10202007262PA (en) Copanlisib biomarkers
PL3075862T3 (pl) Urządzenia i testy do diagnostyki zapalenia zatok przynosowych
EP3376229A4 (en) BIOMARKERS FOR THE DIAGNOSIS OF DEPRESSIONS AND THE USE OF THE BIOMARKER
SG10202007322PA (en) Copanlisib biomarkers
GB201504580D0 (en) Assessment of core samples
GB201614455D0 (en) Biomarkers
GB201719639D0 (en) Setection of biomarkers
SG10201913528PA (en) Methods of diagnosing cancer
ZA202001821B (en) Biomarker
GB201704267D0 (en) Novel biomarker
GB201710858D0 (en) Biomarker
IL261906A (en) Biomarkers for proteopathies and their uses
EP3128326A4 (en) Biomarker for diagnosis of aging or amyotrophia
GB201721723D0 (en) Biomarkers of impaired health
GB201707113D0 (en) Biomarker
GB201613912D0 (en) Predictive biomarker